Clinical Trials Logo

Ragweed Allergy clinical trials

View clinical trials related to Ragweed Allergy.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05346718 Recruiting - Allergic Rhinitis Clinical Trials

Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis

UBAMBI
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The ragweed Ambrosia artemisiifolia is spreading in northern Europe due to climate change. The pollen are considered highly allergenic and might trigger allergy symptoms at much lower concentrations than e.g. grass or birch pollen. This study aims to determine threshold concentrations for ragweed and birch pollen in patients with seasonal allergic rhinitis. Participants will be exposed in an allergen challenge chamber that was technically modified to maintain very low and stable pollen concentrations for several hours. The study design is adaptive, where the pollen concentrations are escalated or de-escalated based on interim analysis of resulting allergic symptoms.